316 related articles for article (PubMed ID: 2269307)
1. Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme.
Renaud JP; Cullin C; Pompon D; Beaune P; Mansuy D
Eur J Biochem; 1990 Dec; 194(3):889-96. PubMed ID: 2269307
[TBL] [Abstract][Full Text] [Related]
2. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
[TBL] [Abstract][Full Text] [Related]
3. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae.
Brian WR; Sari MA; Iwasaki M; Shimada T; Kaminsky LS; Guengerich FP
Biochemistry; 1990 Dec; 29(51):11280-92. PubMed ID: 2271712
[TBL] [Abstract][Full Text] [Related]
4. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
5. Recombinant yeast in drug metabolism.
Renaud JP; Peyronneau MA; Urban P; Truan G; Cullin C; Pompon D; Beaune P; Mansuy D
Toxicology; 1993 Oct; 82(1-3):39-52. PubMed ID: 8236280
[TBL] [Abstract][Full Text] [Related]
6. High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine.
Peyronneau MA; Delaforge M; Riviere R; Renaud JP; Mansuy D
Eur J Biochem; 1994 Aug; 223(3):947-56. PubMed ID: 8055971
[TBL] [Abstract][Full Text] [Related]
7. Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes.
Ramsdell HS; Parkinson A; Eddy AC; Eaton DL
Toxicol Appl Pharmacol; 1991 May; 108(3):436-47. PubMed ID: 1902334
[TBL] [Abstract][Full Text] [Related]
8. Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast.
Ellis SW; Ching MS; Watson PF; Henderson CJ; Simula AP; Lennard MS; Tucker GT; Woods HF
Biochem Pharmacol; 1992 Aug; 44(4):617-20. PubMed ID: 1510710
[TBL] [Abstract][Full Text] [Related]
9. Expression in yeast of three allelic cDNAs coding for human liver P-450 3A4. Different stabilities, binding properties and catalytic activities of the yeast-produced enzymes.
Peyronneau MA; Renaud JP; Jaouen M; Urban P; Cullin C; Pompon D; Mansuy D
Eur J Biochem; 1993 Dec; 218(2):355-61. PubMed ID: 8269924
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
Inui H; Maeda A; Ohkawa H
Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity.
Bork RW; Muto T; Beaune PH; Srivastava PK; Lloyd RS; Guengerich FP
J Biol Chem; 1989 Jan; 264(2):910-9. PubMed ID: 2463251
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P-450 related to P-4504 from phenobarbital-treated rabbit liver: molecular cloning of cDNA and characterization of cytochrome P-450 obtained by its expression in yeast cells.
Imai Y
J Biochem; 1987 May; 101(5):1129-39. PubMed ID: 2820951
[TBL] [Abstract][Full Text] [Related]
13. Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4.
Guengerich FP; Brian WR; Iwasaki M; Sari MA; Bäärnhielm C; Berntsson P
J Med Chem; 1991 Jun; 34(6):1838-44. PubMed ID: 2061924
[TBL] [Abstract][Full Text] [Related]
14. Effects of erythromycin and roxithromycin on oxidation of testosterone and nifedipine catalyzed by CYP3A4 in human liver microsomes.
Yamazaki H; Urano T; Hiroki S; Shimada T
J Toxicol Sci; 1996 Nov; 21(4):215-26. PubMed ID: 8959645
[TBL] [Abstract][Full Text] [Related]
15. Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae.
Brian WR; Srivastava PK; Umbenhauer DR; Lloyd RS; Guengerich FP
Biochemistry; 1989 Jun; 28(12):4993-9. PubMed ID: 2669966
[TBL] [Abstract][Full Text] [Related]
16. Characterization of rabbit liver P450IIE1 synthesized in transformed yeast cells.
Imai Y; Uno T; Nakamura M
J Biochem; 1990 Oct; 108(4):522-4. PubMed ID: 2292581
[TBL] [Abstract][Full Text] [Related]
17. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.
Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF
Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans.
Shimada T; Mimura M; Inoue K; Nakamura S; Oda H; Ohmori S; Yamazaki H
Arch Toxicol; 1997; 71(6):401-8. PubMed ID: 9195021
[TBL] [Abstract][Full Text] [Related]
19. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.
Guengerich FP; Martin MV; Beaune PH; Kremers P; Wolff T; Waxman DJ
J Biol Chem; 1986 Apr; 261(11):5051-60. PubMed ID: 3514607
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
